Status:
UNKNOWN
Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Olympus Corporation of the Americas
Conditions:
Pulmonary Emphysema
Eligibility:
All Genders
40-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Patients with bilateral heterogeneous pulmonary emphysema benefit to differing degrees from unilateral ELVR with complete lobe closure in comparison with incomplete bilateral treatment.
Detailed Description
Patient enrolment and data acquisition is to be carried out on a prospective basis. It is planned to enrol a total of 20 patients with bilateral heterogeneous pulmonary emphysema. All patients will un...
Eligibility Criteria
Inclusion
- age \> 40 inhomogeneous emphysema FEV1 between 20-40% DLCO between 20-40% 6MWT \> 150 m
Exclusion
- pregnant homogeneous disease FEV1 \< 20%
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00995852
Start Date
September 1 2009
End Date
May 1 2011
Last Update
April 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thoraxklinik Heidelberg
Heidelberg, Germany, 69126